This page features the latest news about the Eli Lilly and Co stock. Eli Lilly : More than one-half of patients with Crohn's disease treated with mirikizumab achieved clinical remission at one ...

Eli Lilly & Co. closed 13.93% short of its 52-week high of $972.53, which the company reached on August 22nd.

Eli Lilly's stock dipped slightly by -0.27% to close at $822.51, outperforming the S&P 500’s larger 1.07% drop. Despite a ...

Explore February's least shorted S&P 500 stocks like Alphabet, Mastercard & Chubb. Get insights into trends, short interest, ...

Hutchmed (HCM) stock rises despite a 2024 revenue miss as a cancer drug combo it developed with Innovent Biologics (IVBYI) ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED", the "Company" or "we") (HKEX: 13; Nasdaq/AIM: HCM) today reports its financial r ...